Histopathological Investigation of Progressive Encephalomyelitis with Rigidity and Myoclonus: An Autopsy Case

Hiroyuki Yabata1,2, Ryutaro Nakamura1, Seiji Sugiyama1

  • 1Department of Neurology, Shiga University of Medical Science, Japan.

Insights

Progressive encephalomyelitis with rigidity and myoclonus (PERM) is linked to anti-glycine receptor (GlyR) antibodies. This case suggests PERM symptoms stem from antibody-mediated GlyR internalization, not inflammation.

Area of Science:

  • Neurology
  • Immunology
  • Pathology

Background:

  • Progressive encephalomyelitis with rigidity and myoclonus (PERM) is a rare neurological disorder.
  • PERM is characterized by the presence of anti-glycine receptor (GlyR) antibodies.
  • Clinical presentation often includes rigidity, myoclonus, and autonomic dysfunction.

Purpose of the Study:

  • To report an autopsy case of anti-GlyR antibody-positive PERM.
  • To investigate the pathological basis of severe clinical symptoms in PERM.
  • To explore the mechanism underlying neurological dysfunction in anti-GlyR antibody-associated PERM.

Main Methods:

  • Autopsy case report of an 80-year-old male with anti-GlyR antibody-positive PERM.
  • Clinical assessment including oculomotor dysfunction and autonomic failure.
  • Postmortem neuropathological examination to evaluate inflammatory changes and neuronal loss.

Main Results:

  • The patient presented with severe neurological symptoms, including oculomotor dysfunction and autonomic failure.
  • Despite intensive immunotherapy, neurological symptoms showed minimal improvement.
  • Postmortem findings revealed mild inflammatory changes and neuronal loss, disproportionate to the clinical severity.
  • Antibody-mediated GlyR internalization leading to neuronal disinhibition is proposed as the pathogenic mechanism.

Conclusions:

  • Clinical symptoms in anti-GlyR antibody-positive PERM may be primarily due to antibody-mediated GlyR internalization and subsequent neuronal disinhibition.
  • The findings challenge the notion that severe clinical manifestations are solely driven by a prominent neuroinflammatory signature.
  • This case highlights a potential non-inflammatory mechanism contributing to the pathogenesis of PERM.